The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pressure BioSciences's share price is $0.0045.
Pressure BioSciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.05. Hence, Pressure BioSciences's PS Ratio for today is 0.10.
The historical rank and industry rank for Pressure BioSciences's PS Ratio or its related term are showing as below:
PBIO'
s PS Ratio Range Over the Past 10 Years
Min: 0.02 Med: 3.35 Max: 13.54
Current: 0.1
During the past 13 years, Pressure BioSciences's highest PS Ratio was 13.54. The lowest was 0.02. And the median was 3.35.
PBIO's PS Ratio is ranked better than 98.39% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 3.02
vs PBIO: 0.10
Pressure BioSciences Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Pressure BioSciences was -65.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -38.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -43.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -31.40% per year.
During the past 13 years, Pressure BioSciences's highest 3-Year average Revenue per Share Growth Rate was 125.40% per year. The lowest was -78.50% per year. And the median was -14.90% per year.
Back to Basics: PS Ratio
Pressure BioSciences PS Ratio Historical Data
The historical data trend for Pressure BioSciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pressure BioSciences's PS Ratio
For the Medical Devices subindustry, Pressure BioSciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pressure BioSciences's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Pressure BioSciences's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Pressure BioSciences's Share Price of today is $0.0045. Pressure BioSciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Pressure BioSciences (OTCPK:PBIO) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Pressure BioSciences PS Ratio Related Terms
Thank you for viewing the detailed overview of Pressure BioSciences's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBIO has been successfully added to your 